InsidersTradesSigma
Browse the complete record of transactions filed by Rivard Paul, Directeur Exécutif. Officer active across 1 companies, notably MyMD Pharmaceuticals, Inc.. In total, 2 disclosures have been recorded. Total volume traded: €161k. The latest transaction was filed on 23 November 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Paul Rivard is Executive Vice President of Operations and General Counsel at MyMD Pharmaceuticals, Inc. He oversees the operations and legal matters of the company, bringing his expertise in management and law.